Cash flow Healwell AI Inc.

Equities

AIDX

CA42249X1006

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 15:59:59 2026-01-16 EST			5-day change	1st Jan Change
0.9000 ^CAD	+2.27%		-3.23%	+7.14%

12-10	Canada Competition Bureau obtains a court order to advance probe of Well Health's acquisition of Healwell	RE
11-07	Healwell AI Inc., Q3 2025 Earnings Call, Nov 07, 2025

806158.Zdckpuh6E2NagLiWuVPiGl34ib6aELMSS7jfCSsyjfA.K-RxnqpXUlc90_rQwzSkImmc3vKiXNBzKvO9THtXxbpTgn7hugIqAgjwgA

Published financial data: HEALWELL AI INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	38.57M	47.82M	53.22M	7.32M	38.97M
Total Revenues	38.57M	47.82M	53.22M	7.32M	38.97M
Cost of Goods Sold, Total	31.48M	32.81M	36.6M	6.06M	21.66M
Gross Profit	7.1M	15.01M	16.62M	1.26M	17.32M
Selling General & Admin Expenses, Total	9.59M	33M	29.43M	14.04M	45.7M
Provision for Bad Debts	202K	-	-	-	-
R&D Expenses	-	155K	8.14M	4.81M	5.8M
Depreciation & Amortization - (IS)	2.96M	-	-	-	-
Other Operating Expenses, Total	12.75M	33.15M	37.57M	18.85M	51.5M
Operating Income	-5.65M	-18.14M	-20.95M	-17.59M	-34.18M
Interest Expense, Total	-501K	-462K	-488K	-1.58M	-1.66M
Interest And Investment Income	64K	109K	62K	244K	638K
Net Interest Expenses	-437K	-353K	-426K	-1.34M	-1.02M
Income (Loss) On Equity Invest.	62K	-	-214K	-	-
Other Non Operating Income (Expenses)	1.72M	-103K	-347K	-420K	-1.9M
EBT, Excl. Unusual Items	-4.31M	-18.6M	-21.94M	-19.35M	-37.11M
Impairment of Goodwill	-	-	-	-5.35M	-5.38M
Gain (Loss) On Sale Of Investments	-	-	-395K	-2.31M	277K
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-5.54M	-228K
Insurance Settlements	-	674K	936K	774K	630K
Other Unusual Items	2.97M	1.64M	1.64M	-900K	13.53M
EBT, Incl. Unusual Items	-1.34M	-16.29M	-19.75M	-32.68M	-28.28M
Income Tax Expense	-312K	-747K	1.22M	-542K	-856K
Earnings From Continuing Operations	-1.03M	-15.54M	-20.97M	-32.14M	-27.43M
Earnings Of Discontinued Operations	-	-	-	596K	-54K
Net Income to Company	-1.03M	-15.54M	-20.97M	-31.54M	-27.48M
Minority Interest	-2K	-129K	-115K	-52K	1.19M
Net Income - (IS)	-1.03M	-15.67M	-21.08M	-31.6M	-26.29M
Net Income to Common Incl Extra Items	-1.03M	-15.67M	-21.08M	-31.6M	-26.29M
Net Income to Common Excl. Extra Items	-1.03M	-15.67M	-21.08M	-32.19M	-26.24M
Per Share Items
Net EPS - Basic	-0.03	-0.33	-0.42	-0.55	-0.19
Basic EPS - Continuing Operations	-0.03	-0.33	-0.42	-0.56	-0.19
Basic Weighted Average Shares Outstanding	38.33M	48M	50.08M	57.03M	136M
Net EPS - Diluted	-0.03	-0.33	-0.42	-0.55	-0.19
Diluted EPS - Continuing Operations	-0.03	-0.33	-0.42	-0.56	-0.19
Diluted Weighted Average Shares Outstanding	38.33M	48M	50.08M	57.03M	136M
Normalized Basic EPS	-0.07	-0.24	-0.28	-0.21	-0.16
Normalized Diluted EPS	-0.07	-0.24	-0.28	-0.21	-0.16
Payout Ratio	-195.24	-	-0.55	-	-
Supplemental Items
EBITDA	-5.18M	-17.05M	-19.47M	-16.11M	-32.06M
EBITA	-5.6M	-17.51M	-19.94M	-16.58M	-32.45M
EBIT	-5.65M	-18.14M	-20.95M	-17.59M	-34.18M
EBITDAR	-2.81M	-15.94M	-17.83M	-15.33M	-
Effective Tax Rate - (Ratio)	23.3	4.59	-6.16	1.66	3.03
Total Current Taxes	121K	47K	265K	19K	357K
Total Deferred Taxes	-433K	-794K	952K	-561K	-1.21M
Normalized Net Income	-2.69M	-11.75M	-13.83M	-12.14M	-22M
Interest on Long-Term Debt	497K	466K	488K	452K	707K
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	1.12M	1.66M	1.28M	2.38M
General and Administrative Expenses	7.22M	18.31M	12.29M	9.06M	43.32M
Research And Development Expense From Footnotes	-	155K	8.14M	4.81M	5.8M
Net Rental Expense, Total	2.37M	1.11M	1.64M	787K	-
Imputed Operating Lease Interest Expense	590K	278K	403K	518K	-
Imputed Operating Lease Depreciation	1.78M	829K	1.24M	269K	-
Stock-Based Comp., G&A Exp. (Total)	-	6.11M	3.01M	2.75M	7.14M
Stock-Based Comp., Other (Total)	751K	-	1.82M	509K	-
Total Stock-Based Compensation	751K	6.11M	4.83M	3.26M	7.14M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	894K	7.14M	1.41M	19.16M	9.41M
Total Cash And Short Term Investments	894K	7.14M	1.41M	19.16M	9.41M
Accounts Receivable, Total	4.02M	6.87M	6.02M	1.24M	6.56M
Total Receivables	4.02M	6.87M	6.02M	1.24M	6.56M
Prepaid Expenses	377K	-	-	-	2.35M
Other Current Assets, Total	489K	2.5M	1.17M	2.35M	-
Total Current Assets	5.78M	16.51M	8.6M	22.76M	18.33M
Gross Property Plant And Equipment	37.78M	38.63M	33.84M	17.3M	20.18M
Accumulated Depreciation	-24.2M	-24.7M	-23.39M	-13.56M	-15.26M
Net Property Plant And Equipment	13.57M	13.93M	10.44M	3.73M	4.92M
Long-term Investments	-	4.54M	3.93M	410K	4.11M
Goodwill	151K	10.07M	10.07M	12.3M	67.14M
Other Intangibles, Total	489K	12.45M	11.25M	12.51M	28.3M
Accounts Receivable Long-Term	1.3M	1.44M	860K	249K	366K
Deferred Tax Assets Long-Term	813K	1.56M	152K	-	-
Other Long-Term Assets, Total	251K	390K	319K	1.74M	2.37M
Total Assets	22.36M	60.89M	45.63M	53.7M	126M
Liabilities
Accounts Payable, Total	4.51M	6.55M	5.54M	3.93M	4.33M
Accrued Expenses, Total	2.23M	2.58M	3.28M	1.98M	4.82M
Short-term Borrowings	1.21M	-	7M	-	-
Current Portion of Long-Term Debt	-	-	-	672K	1.78M
Current Portion of Leases	2.54M	3.09M	1.09M	1.01M	946K
Current Income Taxes Payable	126K	177K	230K	19K	373K
Unearned Revenue Current, Total	-	282K	438K	335K	2.45M
Other Current Liabilities	135K	1.82M	1.81M	1.48M	8.61M
Total Current Liabilities	10.74M	14.49M	19.39M	9.42M	23.32M
Long-Term Debt	-	-	-	14.98M	14.24M
Long-Term Leases	11.3M	11.26M	9.33M	4.26M	5.24M
Deferred Tax Liability Non Current	-	2.43M	1.98M	2.02M	6.51M
Other Non Current Liabilities	80K	2.96M	1.44M	1.54M	2.56M
Total Liabilities	22.12M	31.14M	32.14M	32.23M	51.86M
Common Stock, Total	1.01M	39.79M	39.79M	67.37M	140M
Additional Paid In Capital	-	4.81M	9.64M	12.57M	17.29M
Retained Earnings	-897K	-16.57M	-37.65M	-69.25M	-95.22M
Comprehensive Income and Other	-	-	-	1.96M	1.73M
Total Common Equity	114K	28.03M	11.78M	12.65M	63.89M
Minority Interest	123K	1.72M	1.72M	8.81M	9.78M
Total Equity	237K	29.75M	13.49M	21.46M	73.67M
Total Liabilities And Equity	22.36M	60.89M	45.63M	53.7M	126M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	46M	50.08M	53.87M	113M	226M
ECS Total Common Shares Outstanding	40M	50.08M	50.08M	87.99M	169M
Book Value / Share	0	0.56	0.24	0.14	0.38
Tangible Book Value	-526K	5.5M	-9.55M	-12.16M	-31.56M
Tangible Book Value Per Share	-0.01	0.11	-0.19	-0.14	-0.19
Total Debt	15.04M	14.35M	17.42M	20.93M	22.2M
Net Debt	14.15M	7.2M	16.01M	1.77M	12.79M
Debt Equivalent Oper. Leases	18.98M	8.86M	13.1M	6.3M	-
Minority Interest, Total (Incl. Fin. Div)	123K	1.72M	1.72M	8.81M	9.78M
Equity Method Investments, Total	-	2.52M	2.31M	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	6.39M	7.05M	6.44M	3.58M	3.71M
Full Time Employees	340	400	400	102	350
Accumulated Allowance for Doubtful Accounts (Supple)	195K	195K	189K	25K	190K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-1.03M	-15.67M	-21.08M	-31.6M	-26.29M
Depreciation & Amortization - CF	2.9M	3.09M	3.22M	1.79M	1.08M
Amortization of Goodwill and Intangible Assets - (CF)	52K	630K	1.01M	1.01M	1.73M
Depreciation & Amortization, Total	2.96M	3.72M	4.23M	2.8M	2.82M
Amortization of Deferred Charges, Total - (CF)	-	585K	1.05M	1.86M	4.48M
(Gain) Loss From Sale Of Asset	-	-	48K	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	395K	2.31M	-277K
Asset Writedown & Restructuring Costs	-	-	-	10.9M	5.62M
(Income) Loss On Equity Investments - (CF)	-	-	214K	-	-
Stock-Based Compensation (CF)	751K	6.11M	4.83M	3.26M	7.14M
Provision and Write-off of Bad Debts	202K	696K	63K	11K	12K
Net Cash From Discontinued Operations	-	-	-	-2.68M	19K
Other Operating Activities, Total	-388K	-896K	32K	1.28M	-13.31M
Change In Accounts Receivable	-1.22M	-1.5M	695K	4.51M	1.08M
Change In Accounts Payable	3.78M	1.11M	-368K	-3.5M	-1.65M
Change in Unearned Revenues	-	-	156K	-	-1.38M
Change in Other Net Operating Assets	-826K	-1.25M	1.4M	52K	-874K
Cash from Operations	4.22M	-7.1M	-8.35M	-10.8M	-22.62M
Capital Expenditure	-85K	-833K	-312K	-66K	-91K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-5.47M	-	-1.14M	-10.63M
Divestitures	-	-	-	2.5M	-
Sale (Purchase) of Intangible assets	-149K	-1.54M	-856K	-	-1.22M
Investment in Marketable and Equity Securities, Total	-	-810K	-	-410K	-3.43M
Other Investing Activities, Total	-	-	-	473K	-
Cash from Investing	-234K	-8.64M	-1.17M	1.35M	-15.37M
Short Term Debt Issued, Total	-	-	6.79M	3.27M	537K
Long-Term Debt Issued, Total	536K	498K	604K	168K	237K
Total Debt Issued	536K	498K	7.39M	3.44M	774K
Short Term Debt Repaid, Total	-43K	-1.92M	-	-1.68M	-
Long-Term Debt Repaid, Total	-2.71M	-3.2M	-3.49M	-576K	-1.17M
Total Debt Repaid	-2.75M	-5.12M	-3.49M	-2.26M	-1.17M
Issuance of Common Stock	-	27.54M	-	17.45M	19.39M
Repurchase of Common Stock	-	-870K	-	-	-625K
Common Dividends Paid	-2.01M	-	-116K	-	-
Common & Preferred Stock Dividends Paid	-2.01M	-	-116K	-	-
Other Financing Activities, Total	-	-63K	-	8.57M	9.88M
Cash from Financing	-4.22M	21.99M	3.78M	27.2M	28.24M
Net Change in Cash	-234K	6.25M	-5.73M	17.75M	-9.75M
Supplemental Items
Levered Free Cash Flow	1.57M	-3.65M	-2.39M	-4.1M	-1.74M
Unlevered Free Cash Flow	1.88M	-3.36M	-2.08M	-3.11M	-704K
Change In Net Working Capital	-1.94M	76K	-2.07M	-37K	-7.53M
Net Debt Issued / Repaid	-2.21M	-4.62M	3.9M	1.18M	-394K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-15.69	-27.24	-24.58	-22.14	-23.84
Return on Total Capital	-20.34	-38.19	-34.91	-30	-30.91
Return On Equity %	-82.19	-103.67	-96.99	-183.88	-57.66
Return on Common Equity	-91.26	-111.37	-105.95	-263.61	-68.57
Margin Analysis
Gross Profit Margin %	18.4	31.39	31.23	17.18	44.43
SG&A Margin	24.87	69.01	55.29	191.85	117.28
EBITDA Margin %	-13.44	-35.66	-36.58	-220.21	-82.25
EBITA Margin %	-14.52	-36.62	-37.46	-226.62	-83.27
EBIT Margin %	-14.66	-37.94	-39.36	-240.43	-87.72
Income From Continuing Operations Margin %	-2.66	-32.5	-39.4	-439.26	-70.37
Net Income Margin %	-2.67	-32.77	-39.62	-431.83	-67.47
Net Avail. For Common Margin %	-2.67	-32.77	-39.62	-439.98	-67.33
Normalized Net Income Margin	-6.98	-24.58	-25.98	-165.97	-56.46
Levered Free Cash Flow Margin	4.06	-7.64	-4.49	-55.99	-4.46
Unlevered Free Cash Flow Margin	4.87	-7.03	-3.92	-42.5	-1.81
Asset Turnover
Asset Turnover	1.71	1.15	1	0.15	0.43
Fixed Assets Turnover	2.62	3.48	4.37	1.03	9.01
Receivables Turnover (Average Receivables)	10.97	8.78	8.26	2.02	9.99
Short Term Liquidity
Current Ratio	0.54	1.14	0.44	2.42	0.79
Quick Ratio	0.46	0.97	0.38	2.17	0.69
Operating Cash Flow to Current Liabilities	0.39	-0.49	-0.43	-1.15	-0.97
Days Sales Outstanding (Average Receivables)	33.36	41.56	44.2	181.1	36.65
Average Days Payable Outstanding	40.3	61.5	60.29	285.37	69.84
Long Term Solvency
Total Debt/Equity	6.35K	48.23	129.09	97.5	30.14
Total Debt / Total Capital	98.45	32.54	56.35	49.37	23.16
LT Debt/Equity	4.77K	37.86	69.17	89.67	26.44
Long-Term Debt / Total Capital	73.94	25.54	30.19	45.4	20.31
Total Liabilities / Total Assets	98.94	51.15	70.43	60.03	41.31
EBIT / Interest Expense	-11.29	-39.27	-42.93	-11.14	-20.63
EBITDA / Interest Expense	-5.39	-31.21	-34.27	-9.37	-18.93
(EBITDA - Capex) / Interest Expense	-5.56	-33.01	-34.91	-9.41	-18.99
Total Debt / EBITDA	-5.57	-1	-1.04	-1.41	-0.71
Net Debt / EBITDA	-5.24	-0.5	-0.96	-0.12	-0.41
Total Debt / (EBITDA - Capex)	-5.4	-0.94	-1.02	-1.41	-0.71
Net Debt / (EBITDA - Capex)	-5.08	-0.47	-0.94	-0.12	-0.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-16.67	23.96	11.3	-29.81	432.62
Gross Profit, 1 Yr. Growth %	0.21	16.15	10.72	-66.12	1.28K
EBITDA, 1 Yr. Growth %	352.27	392.69	14.16	-3.66	98.94
EBITA, 1 Yr. Growth %	240.55	351.31	13.86	-3.58	95.71
EBIT, 1 Yr. Growth %	233.18	361.37	15.48	-3.39	94.32
Earnings From Cont. Operations, 1 Yr. Growth %	748.76	1.41K	34.93	76.65	-14.67
Net Income, 1 Yr. Growth %	743.44	1.42K	34.56	49.86	-16.79
Normalized Net Income, 1 Yr. Growth %	29.42K	321.68	17.64	0.98	81.2
Diluted EPS Before Extra, 1 Yr. Growth %	736.23	1.12K	28.98	54.38	-65.71
Accounts Receivable, 1 Yr. Growth %	33.31	70.98	-12.37	-79.39	428.93
Net Property, Plant and Equip., 1 Yr. Growth %	-14.26	2.65	-25.04	-64.25	31.66
Total Assets, 1 Yr. Growth %	-1.44	172.34	-25.06	17.68	133.79
Tangible Book Value, 1 Yr. Growth %	-128.29	-1.15K	-273.47	27.39	159.51
Common Equity, 1 Yr. Growth %	-94.68	24.48K	-57.99	7.43	405.04
Cash From Operations, 1 Yr. Growth %	31.4	-268.12	17.58	29.38	109.47
Capital Expenditures, 1 Yr. Growth %	-30.33	880	-62.55	-77.4	37.88
Levered Free Cash Flow, 1 Yr. Growth %	31.02	-237.98	-34.54	455.23	-57.55
Unlevered Free Cash Flow, 1 Yr. Growth %	22.81	-213.72	-37.99	784.46	-77.38
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-7.48	1.63	17.46	-60.88	93.36
Gross Profit, 2 Yr. CAGR %	1.2	45.6	13.4	-71.06	116.04
EBITDA, 2 Yr. CAGR %	104.48	285.74	137.16	-2.79	38.44
EBITA, 2 Yr. CAGR %	80.61	226.27	126.69	-2.69	37.37
EBIT, 2 Yr. CAGR %	78.74	226.96	130.83	-1.52	37.02
Earnings From Cont. Operations, 2 Yr. CAGR %	105.96	1.03K	351.87	43.81	22.77
Net Income, 2 Yr. CAGR %	111.91	1.03K	352.67	42	11.67
Normalized Net Income, 2 Yr. CAGR %	376.58	3.49K	122.73	1.65	35.27
Diluted EPS Before Extra, 2 Yr. CAGR %	-	908.48	296.06	31.49	-27.24
Accounts Receivable, 2 Yr. CAGR %	7.56	50.98	22.4	-57.5	4.42
Net Property, Plant and Equip., 2 Yr. CAGR %	-12.07	-6.19	-12.28	-48.23	-31.4
Total Assets, 2 Yr. CAGR %	-5.88	63.84	42.86	-6.09	65.87
Tangible Book Value, 2 Yr. CAGR %	-47.75	72.05	326.01	48.66	81.82
Common Equity, 2 Yr. CAGR %	-77.55	261.8	916.31	-32.82	132.93
Cash From Operations, 2 Yr. CAGR %	7.39	48.63	40.6	23.34	64.63
Capital Expenditures, 2 Yr. CAGR %	-33.47	161.3	91.59	-71.85	-44.18
Levered Free Cash Flow, 2 Yr. CAGR %	-	74.71	-4.96	5.93	53.53
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	48.19	-16.03	-3.82	41.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.95	2	4.76	-42.54	-6.59
Gross Profit, 3 Yr. CAGR %	0.7	29.39	32.9	-54.01	4.87
EBITDA, 3 Yr. CAGR %	68.52	139.61	157.06	66.98	23.42
EBITA, 3 Yr. CAGR %	54.91	116.85	129.71	62.28	22.83
EBIT, 3 Yr. CAGR %	54.49	117.23	131.12	64.78	23.52
Earnings From Cont. Operations, 3 Yr. CAGR %	437.27	300.4	457.53	215.13	20.84
Net Income, 3 Yr. CAGR %	612.57	308.94	457.02	213.14	18.83
Normalized Net Income, 3 Yr. CAGR %	946.34	362.77	1.05K	63.33	23.25
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	408.1	176.02	-15.99
Accounts Receivable, 3 Yr. CAGR %	-	25.53	25.94	-32.4	-1.51
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-7.42	-12.95	-34.97	-29.34
Total Assets, 3 Yr. CAGR %	-	34.12	26.23	33.92	27.27
Tangible Book Value, 3 Yr. CAGR %	-	41.88	72.52	184.88	79
Common Equity, 3 Yr. CAGR %	-	131.41	76.51	380.54	31.61
Cash From Operations, 3 Yr. CAGR %	6.36	24.69	37.46	36.75	47.16
Capital Expenditures, 3 Yr. CAGR %	-39.38	63.09	36.75	-8.09	-52.2
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	25.95	15.69	-21.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	10.84	1.7	-40.63
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	4.1	-30.48	-3.38
Gross Profit, 5 Yr. CAGR %	-	-	19.05	-28.92	19.58
EBITDA, 5 Yr. CAGR %	-	-	78.21	67.02	94.69
EBITA, 5 Yr. CAGR %	-	-	67.61	57.38	81.56
EBIT, 5 Yr. CAGR %	-	-	68.7	58.3	82.32
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	401.33	165.83	195.85
Net Income, 5 Yr. CAGR %	-	-	494.3	167.86	192.88
Normalized Net Income, 5 Yr. CAGR %	-	-	467.4	152.39	374.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	127.02
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-18.6	16.84
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-26.63	-20.86
Total Assets, 5 Yr. CAGR %	-	-	-	16.3	40.8
Tangible Book Value, 5 Yr. CAGR %	-	-	-	44.55	76.18
Common Equity, 5 Yr. CAGR %	-	-	-	41.1	97.22
Cash From Operations, 5 Yr. CAGR %	-	-	18.92	24.15	47.74
Capital Expenditures, 5 Yr. CAGR %	-	-	-3.95	-19.23	-5.69
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	7.78
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-14.4